Kidney Cancer VA Rating

Overview

Renal cell carcinoma is the most common form. Often treated with partial or full nephrectomy.

Post-nephrectomy residuals are rated under the Renal Dysfunction formula based on labs (creatinine, BUN), proteinuria, and hypertension.

In Depth

Kidney cancer is included in the PACT Act presumptive list for veterans with qualifying toxic-exposure service, and can also be service connected on a direct basis where the exposure and medical evidence support it.

Active malignancy is evaluated at 100 percent under 38 CFR § 4.115b, Diagnostic Code 7528 for malignant neoplasms of the genitourinary system. Malignancies rated at 100 percent under 38 CFR Part 4 carry a note directing that the total evaluation continues during active disease and for six months following the cessation of surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. VA must then schedule a mandatory examination, and any reduction from the 100 percent evaluation is made under the procedures in 38 CFR § 3.105(e) — advance written notice, at least 60 days to submit evidence, and 30 days to request a predetermination hearing. If the mandatory exam did not happen, or the notice period was not honored, that is a procedural issue separate from the medical question of how bad the residuals are.

After the convalescent period, DC 7528 directs evaluation on residuals as voiding dysfunction or renal dysfunction, whichever is predominant. After a nephrectomy the renal path usually governs, and renal dysfunction under 38 CFR § 4.115a is rated on objective measures — creatinine, BUN, blood pressure readings, edema, and the presence of persistent albuminuria — not on how the veteran feels.

Hypertension frequently follows nephrectomy and is a recognized consequence worth evaluating in its own right. So is the surgical scar. Both are routinely omitted from a residuals decision that addresses only renal laboratory values.

How to Establish Service Connection

• Presumptive (PACT Act).
• Agent Orange consideration for Vietnam-era veterans.
• Direct connection with documented carcinogen exposure.

Rating Criteria

Paraphrased from 38 CFR § 4.115b, DC 7528 (analogous); PACT Act presumptive (38 CFR § 3.320)

See what each percentage pays in 2026 and how it combines with your current rating →

Evidence Checklist

• Pathology.
• Operative report.
• Post-op labs (creatinine, BUN, GFR).
• Exposure documentation.

Evidence VA Commonly Cites in These Claims

Descriptive summary of evidence types frequently referenced in rating decisions for this condition. Not a checklist of actions to take — every claim is decided on its own facts.

• ★Get the pathology report and the oncology treatment summary into the file — the dates therapy started and stopped are what set the six-month convalescent window.
• ★List every residual separately when the issue is evaluated after treatment; residuals that are never identified are generally never rated.
• ★Ask the treating oncologist to document ongoing surveillance, maintenance therapy, or hormone therapy where it applies — continuing therapy can be relevant to whether the active-disease evaluation should have continued.
• ★For presumptive exposure, put the service documentation in the file: DD-214, unit assignments, deployment orders, or the location and date range establishing covered service.
• ★Where a reduction from 100 percent is proposed, respond within the 60-day evidence window and request the predetermination hearing within 30 days if you want one — those windows are separate.
• ★Get the nephrology labs — creatinine, eGFR, BUN, urinalysis with albumin — dated close to the evaluation.
• ★Log blood pressure readings; the renal dysfunction criteria reference diastolic pressure levels.
• ★Claim the surgical scar and any post-nephrectomy hypertension separately.

Illustrative Scenarios

These are hypothetical educational examples — not actual case results, predictions, or guarantees of outcomes.

Common pitfalls VA sees

• Assuming the 100 percent evaluation continues indefinitely. It does not; the schedule contemplates reevaluation six months after therapy ends.
• Letting the mandatory post-treatment examination pass without documenting residuals, then disagreeing only after the reduction takes effect.
• Claiming only the cancer and never claiming the neuropathy, scars, fatigue, endocrine, or mental health residuals it produced.
• Missing the 60-day evidence window in a proposed-reduction letter because it looks like a form letter rather than a deadline.

Common Secondary Conditions

Conditions frequently service-connected as secondary to Kidney Cancer:

What the C&P Exam Documents

General information about how this condition is typically evaluated. This is not coaching on what to say and is not a substitute for medical or legal advice.

• →Bring recent labs; the examiner may not have them.
• →Report edema, fatigue, and any dietary or fluid restriction.
• →Mention blood pressure medication changes since surgery.

Frequently Asked Questions